FrancophonIA/ELRC3.0 huggingface dataset:
English: − Skin reactions (redness and swelling) at the infusion site, rash, itching.
Icelandic: - Húðviðbrögð (roði og bólga) á innrennslisstað, útbrot, kláði.
English: Your doctor should do a blood test to check your kidney function before each dose of Zoledronic Acid Hospira.
Icelandic: Læknirinn á að láta gera blóðrannsókn til þess að rannsaka starfsemi nýrnanna fyrir gjöf hvers skammts af Zoledronic Acid Hospira.
English: − Unusual fracture of the thigh bone particularly in patients on long-term treatment for osteoporosis may occur rarely.
Icelandic: - Í mjög sjaldgæfum tilvikum geta óvenjuleg brot á lærlegg komið fyrir, sérstaklega hjá sjúklingum á langtímameðferð við beinþynningu.
English: Zoledronic acid treatment should be resumed at the same dose as that given prior to treatment interruption.
Icelandic: Meðferð með zoledronsýru skal haldið áfram með sama skammti og gefinn var áður en meðferð var rofin.
English: Remove the following amount of Zoledronic Acid Hospira 4 mg/100 ml solution for infusion (ml)
Icelandic: Fjarlægið eftirfarandi magn af Zoledronic Acid Hospira 4 mg/100 ml innrennslislyfi, lausn (ml)
English: Hypersensitivity reactions including rare cases of bronchoconstriction, urticaria and angioedema, and very rare cases of anaphylactic reaction/shock
Icelandic: Tíðni ekki þekkt** Ofnæmisviðbrögð, þar með talin mjög sjaldgæf tilvik berkjuþrenginga, ofsakláða og ofsabjúgs og tilvik bráðaofnæmis/losts sem koma örsjaldan fyrir
English: Patients were evenly distributed between zoledronic acid -treated and placebo groups.
Icelandic: Sjúklingum var skipt jafnt í hóp sem fékk meðferð með zoledronsýru og hóp sem fékk lyfleysu.
English: Other products containing zoledronic acid as active substance are available for osteoporosis indications and treatment of Paget´s disease of the bone.
Icelandic: Önnur lyf sem innihalda zoledronsýru sem virkt efni eru fáanleg við beinþynningu og meðferðar við Pagetssjúkdómi í beinum.
English: What Zoledronic Acid Hospira is and what it is used for What you need to know before you are given Zoledronic Acid Hospira How Zoledronic Acid Hospira is used Possible side effects
Icelandic: Acid Hospira og við hverju það er notað Áður en byrjað er að gefa þér Zoledronic Acid Hospira Hvernig gefa
English: •Breast-feeding (see section 4.6).
Icelandic: - Brjóstagjöf (sjá kafla 4.6).
English: How often Zoledronic Acid Hospira is given - If you are being treated for the prevention of bone complications due to bone metastases, you will be given one infusion of Zoledronic Acid Hospira every three to four weeks.
Icelandic: - Ef þú ert á meðferð til að koma í veg fyrir fylgikvilla í beinum vegna meinvarpa í beinum færð þú eitt innrennsli með Zoledronic Acid Hospira á þriggja til fjögurra vikna fresti.
English: Zoledronic Acid Hospira must not be mixed or given intravenously with any other medicinal products.
Icelandic: Hvorki má blanda Zoledronic Acid Hospira við nein önnur lyf né gefa það í bláæð með neinum öðrum lyfjum.
English: Zoledronic Acid Hospira contains sodium
Icelandic: Zoledronic Acid Hospira inniheldur natríum
English: • Patients, especially elderly patients and those receiving diuretic therapy, should be appropriately hydrated prior to administration of zoledronic acid.
Icelandic: - Tryggja verður viðeigandi vökvagjöf fyrir sjúklinga, sér í lagi fyrir aldraða sjúklinga og þá sem eru á þvagræsilyfjum, áður en zoledronsýra er gefin.
English: Zoledronic acid was well tolerated when administered subcutaneously to rats and intravenously to dogs at doses up to 0.02 mg/kg daily for 4 weeks.
Icelandic: Í meðallagi langvarandi og langvarandi eiturverkanir Rottur, sem gefin var zoledronsýra undir húð, og hundar, sem gefin var zoledronsýra í bláæð, þoldu hana vel í skömmtum allt að 0,02 mg/kg daglega í fjórar vikur.
English: Zoledronic Acid Hospira is supplied as packs containing 1 bag.
Icelandic: Pakkningastærð Zoledronic Acid Hospira er í pakkningum sem innihalda 1 poka.
English: Aseptic techniques must be followed during preparation of the infusion.
Icelandic: Viðhafa skal smitgát við undirbúning innrennslisins.
English: The following risk factors should be considered when evaluating an individual's risk of developing ONJ: - Potency of the bisphosphonate (higher risk for highly potent compounds), route of administration (higher risk for parenteral administration) and cumulative dose of bisphosphonate.
Icelandic: - Styrk bisfosfonatsins (meiri áhætta fylgir öflugri lyfjum), íkomuleið (meiri áhætta fylgir gjöf í blóðrás) og uppsafnaðan skammt bisfosfonats.
English: Zoledronic Acid Hospira 4 mg/5 ml sterile concentrate IV
Icelandic: Zoledronic Acid Hospira 4 mg/5 ml sæft þykkni i.v.
English: The following are the important identified risks with zoledronic acid in the approved indications:
Icelandic: Eftirtalið er skilgreint sem mikilvæg áhætta vegna notkunar zoledronsýru við samþykktum ábendingum:
English: Zoledronic Acid Hospira treatment should be resumed at the same dose as that given prior to treatment interruption.
Icelandic: Acid Hospira skal haldið áfram með sama skammti og gefinn var áður en meðferð var rofin.
English: Your doctor should do a blood test to check your kidney function (levels of creatinine) before each dose of Zoledronic Acid Hospira.
Icelandic: Læknirinn á að láta gera blóðrannsókn til þess að rannsaka starfsemi nýrnanna (magn kreatinins) fyrir gjöf hvers skammts af Zoledronic Acid Hospira.
English: Pfizer Luxembourg SARL Pfizer, podružnica za svetovanje s področja farmacevtske dejavnosti, Ljubljana
Icelandic: Pfizer Luxembourg SARL Eesti filiaal
English: In the pooled results, a similar decrease in pain severity and pain interference scores relative to baseline were observed over 6 months for zoledronic acid and risedronate.
Icelandic: Í sameinuðum upplýsingum sást eftir 6 mánuði svipuð minnkun í skori alvarleika verkja og áhrifa verkja á daglegt líf, samanborið við upphafsgildi, fyrir zoledronsýru og risedronat.
English: In clinical trials with zoledronic acid, patients with serum creatinine > 265 µmol/l or > 3.0 mg/dl were excluded.
Icelandic: Sjúklingar með sermisþéttni kreatíníns >265 μmól/l eða >3,0 mg/dl fengu ekki að taka þátt í klínísku rannsóknunum.
English: Your doctor can recommend a mild pain reliever such as ibuprofen or paracetamol to reduce these side effects.
Icelandic: Læknirinn mælir hugsanlega með vægu verkjalyfi svo sem íbúprófeni eða parasetamóli til þess að draga úr þessum aukaverkunum.
English: Zoledronic acid is contraindicated in breast-feeding women (see section 4.3).
Icelandic: Brjóstagjöf er frábending fyrir notkun zoledronsýru (sjá kafla 4.3).
English: For information on the infusion of Zoledronic Acid Hospira, see section 6.6.
Icelandic: Sjá kafla 6.6 varðandi upplýsingar um innrennsli Zoledronic Acid Hospira.
English: The hydration status of patients must be assessed prior to and following administration of zoledronic acid to ensure that they are adequately hydrated.
Icelandic: Meta verður vökvaástand sjúklings fyrir og eftir gjöf Zoledronic Acid Hospira, til að tryggja að sjúklingurinn sé í góðu vökvajafnvægi.
English: − Osteonecrosis has also very rarely been seen occurring with other bones than the jaw, especially the hip or thigh.
Icelandic: Örsjaldan hefur beindrep komið fram í öðrum beinum en í kjálkanum, sérstaklega í mjöðm eða í læri.
English: Pharmacodynamic effects
Icelandic: Lyfjaflokkstengd áhrif)
English: − The other ingredients are: mannitol, sodium citrate, sodium chloride and water for injections.
Icelandic: - Önnur innihaldsefni eru: mannitól, natríumsítrat, natríumklóríð og vatn fyrir stungulyf.
English: In the event of overdose leading to clinically significant hypocalcaemia, reversal may be achieved with supplemental oral calcium and/or an intravenous infusion of calcium gluconate.
Icelandic: Við ofskömmtun sem leiðir til klínískt marktækrar blóðkalsíumlækkunar má snúa því ástandi við með inntöku kalsíumuppbótar og/eða með innrennsli kalsíumglúkonats í bláæð.
English: Cases of osteonecrosis of the jaw have been reported, predominantly in cancer patients treated with medicinal products that inhibit bone resorption, such as zoledronic acid (see section 4.4).
Icelandic: Greint hefur verið frá tilvikum um beindrep í kjálka, einkum hjá krabbameinssjúklingum sem fá meðferð lyfjum sem hamla beineyðingu, svo sem zoledronsýru (sjá kafla 4.4).
English: − Hypersensitivity reactions.
Icelandic: - Ofnæmisviðbrögð.
English: − Irregular heart rhythm (atrial fibrillation) has been seen in patients receiving zoledronic acid for postmenopausal osteoporosis.
Icelandic: - Óreglulegur hjartsláttur (gáttatif) hefur komið fram hjá sjúklingum sem fá zoledronsýru við beinþynningu eftir tíðahvörf.
English: In Phase I dose
Icelandic: LYFSINS ÞAR SEM VIÐ Á
English: Talk to your doctor before you are given Zoledronic Acid Hospira: - if you are being treated with any medicine containing zoledronic acid, which is also the active substance of Zoledronic Acid Hospira (zoledronic acid is used in adult patients with certain types of cancer to prevent bone complications or to reduce the amount of calcium).
Icelandic: Leitið ráða hjá lækninum áður en þér er gefið Zoledronic Acid Hospira: - ef þú færð annað lyf sem inniheldur zoledronsýru, sem er virka efnið í Zoledronic Acid Hospira
English: Serum calcium should be measured and hypocalcaemia must be corrected before initiating zoledronic acid therapy.
Icelandic: Mæla skal kalsíumþéttni í sermi og leiðrétta verður blóðkalsíumlækkun áður en meðferð með zoledronsýru er hafin.
English: 1 intravenous bag
Icelandic: INNRI UMBÚÐUM LÍTILLA EININGA
English: Hypophosphataemia
Icelandic: Blóðfosfatlækkun
English: − Difficulty in breathing with wheezing or coughing.
Icelandic: - Öndunarerfiðleikar ásamt hvæsandi öndun eða hósta.
English: How to store Zoledronic Acid Hospira
Icelandic: Hvernig geyma á Zoledronic Acid Hospira
English: In the clinical studies, patients with serum creatinine > 400 µmol/l or > 4.5 mg/dl were excluded.
Icelandic: Sjúklingar með sermisþéttni kreatíníns >400 μmól/l eða >4,5 mg/dl fengu ekki að taka þátt í klínísku rannsóknunum.
English: While on treatment, invasive dental procedures should be performed with caution and avoided in close proximity to zoledronic acid treatment.
Icelandic: Gæta skal varúðar við ífarandi tannaðgerðir meðan á meðferð stendur og forðast skal slíkar aðgerðir í tímalegri nálægð við meðferð með zoledronsýru.
English: Zoledronic Acid Hospira must not be mixed or given intravenously with any other medicinal product and must be given through a separate infusion line at a constant infusion rate.
Icelandic: Hvorki má blanda Zoledronic Acid Hospira við önnur lyf né gefa það í bláæð með öðrum lyfjum og lyfið verður að gefa um aðskilda innrennslislögn með jöfnum innrennslishraða.
English: Uncommon Blood creatinine increased, pollakiuria, proteinuria
Icelandic: Aukning á kreatíníni og þvagefni í blóði, blóðkalsíumlækkun
English: Uncommon: Blurred vision, scleritis and orbital inflammation Rare
Icelandic: Þokusjón, hvítubólga (scleritis) og bólga í augntóttum
English: Within three days after zoledronic acid administration, an acute phase reaction has commonly been reported, with symptoms including bone pain, fever, fatigue, arthralgia, myalgia, rigors and arthritis with subsequent joint swelling; these symptoms usually resolve within a few days (see description of selected adverse reactions).
Icelandic: Algengt er að greint hafi verið frá bráðri bólgusvörun (acute phase reaction) innan þriggja daga frá gjöf zoledronsýru, með einkennum á borð við beinverki, hita, þreytu, liðverki, vöðvaverki, kuldahroll og liðbólgu sem fylgir þroti í liðum.
English: Instructions for preparing reduced doses of Zoledronic Acid Hospira
Icelandic: Leiðbeiningar um blöndun minni skammta Zoledronic Acid Hospira
English: Concentrate for solution for infusion (sterile concentrate)
Icelandic: Innrennslisþykkni, lausn (sæft þykkni)
English: Prevention of skeletal related events in patients with advanced malignancies involving bone:
Icelandic: Vörn gegn sjúkdómseinkennum frá beinum hjá sjúklingum með langt gengna illkynja sjúkdóma er finnast í beinum:
English: Headache, dizziness, sickness, vomiting, diarrhoea, pain in the muscles, pain in the bones and/or joints, pain in the back, arms or legs, flu-like symptoms (e.g. tiredness, chills, joint and muscle pain), chills, feeling of tiredness and lack of interest, weakness, pain, feeling unwell, swelling and/or pain at the infusion site.
Icelandic: Algengar aukaverkanir (geta komið fyrir hjá allt að 1 af hverjum 10 einstaklingum) Höfuðverkur, sundl, ógleði, uppköst, niðurgangur, vöðvaverkir, beinverkir og/eða liðverkir, verkir í baki, handleggjum eða fótleggjum, flensulík einkenni (t.d. þreyta, kuldaskjálfti, lið- og vöðvaverkir), kuldaskjálfti, þreytutilfinning og áhugaleysi, máttleysi, verkir, vanlíðan, þroti og/eða verkur á innrennslisstað.
English: Following initiation of therapy, serum creatinine should be measured prior to each dose of zoledronic acid and treatment should be withheld if renal function has deteriorated.
Icelandic: Eftir að meðferð er hafin skal mæla sermisþéttni kreatíníns fyrir hverja gjöf zoledronsýru og ekki skal veita meðferð hafi nýrnastarfsemi versnað.
English: It also contains mannitol, sodium citrate and water for injections.
Icelandic: Lyfið inniheldur einnig mannitól, natríumsítrat og vatn fyrir stungulyf.
English: Atypical subtrochanteric and diaphyseal femoral fractures (bisphosphonate class adverse reaction).
Icelandic: Afbrigðileg neðanlærhnútubrot og brot á lærleggsbol (aukaverkun af lyfjum í flokki bisfosfonata).
English: − Gastrointestinal reactions such as nausea and vomiting as well as loss of appetite.
Icelandic: - Einkenni frá meltingarfærum svo sem ógleði og uppköst, sem og lystarleysi.
English: - For single use only.
Icelandic: - Eingöngu einnota.
English: Zoledronic Acid Hospira 5 mg/100 ml solution for infusion
Icelandic: Zoledronic Acid Hospira 5 mg/100 ml innrennslislausn inniheldur
English: Table 3: Efficacy results (solid tumours other than breast or prostate cancer) Any SRE (+TIH)
Icelandic: Verkunarniðurstöður (föst æxli önnur en krabbamein í brjóstum eða blöðruhálskirtli) Einhver sjúkdómseinkenni frá beinum (+ blóðkalsíumhækkun vegna æxla)
English: For storage conditions of the diluted solution for infusion, see section 6.3.
Icelandic: Geymsluskilyrði eftir þynningu innrennslislausnar, sjá kafla 6.3.
English: The most frequent finding in repeat-dose studies consisted of increased primary spongiosa in the metaphyses of long bones in growing animals at nearly all doses, a finding that reflected the compound's pharmacological antiresorptive activity.
Icelandic: á endurteknum skömmtum var aukið frumkomið beinfrauð í vaxtarlínum langra beina hjá dýrum í vexti, við nærri alla skammtana, en þetta endurspeglar lyfhrif efnisins sem verkar gegn beineyðingu.
English: Measurement of serum calcium before infusion of zoledronic acid is recommended for patients with Paget´s disease.
Icelandic: Mælt er með því að kalsíumþéttni í sermi sé mæld, hjá sjúklingum með Pagetssjúkdóm, áður en innrennsli zoledronsýru er gefið.
English: Hypocalcaemia has been reported in patients treated with zoledronic acid.
Icelandic: Greint hefur verið frá blóðkalsíumlækkun hjá sjúklingum á meðferð með zoledronsýru.
English: Convulsions, hypoaesthesia and tetany (secondary to hypocalcaemia)
Icelandic: Krampar, tilfinningadofi í húð og kalkstjarfi (tetany) (afleiðingar blóðkalsíumlækkunar).
English: ONJ has been reported in the post-marketing setting in patients receiving zoledronic acid for osteoporosis (see section 4.8).
Icelandic: Greint hefur verið frá beindrepi í kjálka eftir markaðssetningu lyfsins, hjá sjúklingum á meðferð með zoledronsýru við beinþynningu (sjá kafla 4.8).
English: One ml solution contains 0.05 mg zoledronic acid (as monohydrate).
Icelandic: Einn ml af lausn inniheldur 0,05 mg af zoledronsýru (sem einhýdrat).
English: − From a microbiological point of view, the diluted solution for infusion should be used immediately.
Icelandic: - Með hliðsjón af örverumengun á að nota þynnta innrennslislausnina strax.
English: - The other ingredients are mannitol, sodium citrate and water for injections.
Icelandic: - Önnur innihaldsefni eru: mannitól, natríumsítrat og vatn fyrir stungulyf.
English: Zoledronic Acid Hospira is supplied as packs containing 1 vial.
Icelandic: Zoledronic Acid Hospira er í pakkningum sem innihalda 1 hettuglas.
English: Zoledronic Acid
Icelandic: á Zoledronic Acid Hospira
English: Table 2: Efficacy results (prostate cancer patients receiving hormonal therapy) Any SRE (+TIH)
Icelandic: Verkunarniðurstöður (sjúklingar með krabbamein í blöðruhálskirtli sem fá hormónameðferð) Einhver sjúkdómseinkenni frá beinum (+ blóðkalsíumhækkun vegna æxla)
English: − The other ingredients are: mannitol, sodium citrate, water for injections.
Icelandic: - Önnur innihaldsefni eru: mannitól, natríumsítrat, vatn fyrir stungulyf.
English: VIAL LABEL
Icelandic: Pakkningastærð
English: Each bag with 100 ml of solution contains 4 mg zoledronic acid (as monohydrate).
Icelandic: Hver poki með 100 ml af lausn inniheldur 4 mg af zoledronsýru (sem einhýdrat).
English: Sodium citrate Sodium chloride Water for injections
Icelandic: Natríumsítrat Natríumklóríð Vatn fyrir stungulyf
English: − Chest pain.
Icelandic: - Brjóstverkur.
English: A side effect called osteonecrosis of the jaw (ONJ) (bone damage in the jaw) has been reported in the post-marketing setting in patients receiving zoledronic acid for osteoporosis.
Icelandic: Greint hefur verið frá aukaverkun sem kallast beindrep í kjálka (skemmdir á kjálkabeini) hjá sjúklingum á meðferð með zoledronsýru við beinþynningu eftir markaðssetningu þess.
English: The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch
Icelandic: Heiti og heimilisfang framleiðanda sem er ábyrgur fyrir lokasamþykkt viðkomandi lotu skal koma fram í prentuðum fylgiseðli.
English: Each ml of the solution contains 0.05 mg zoledronic acid anhydrous (as monohydrate).
Icelandic: Hver ml af lausninni inniheldur 0,05 mg af zoledronsýru (sem einhýdrat).
English: Episcleritis
Icelandic: Hospira
English: One bag with 100 ml contains 4 mg zoledronic acid (as monohydrate).
Icelandic: Einn poki með 100 ml inniheldur 4 mg af zoledronsýru (sem einhýdrat).
English: What Zoledronic Acid Hospira looks like and contents of the pack Zoledronic Acid Hospira is a clear and colourless solution.
Icelandic: Lýsing á útliti Zoledronic Acid Hospira og pakkningastærðir Zoledronic Acid Hospira er tær og litlaus lausn í 100 ml plastpokum, tilbúin til innrennslis.
English: Table 5: Efficacy results (breast cancer and multiple myeloma patients)
Icelandic: Verkunarniðurstöður (sjúklingar með brjóstakrabbamein og mergæxlager)
English: − Headache and a flu-like syndrome consisting of fever, fatigue, weakness, drowsiness, chills and bone, joint and/or muscle ache.
Icelandic: - Höfuðverkur og flensulík einkenni, þ.e. hiti, þreyta, lasleiki, syfja, kuldahrollur og beinverkir,
English: The use of Zoledronic Acid Hospira in patients with severe renal impairment (creatinine clearance < 35 ml/min) is contraindicated due to an increased risk of renal failure in this population.
Icelandic: Acid Hospira handa sjúklingum með verulega skerta nýrnastarfsemi (úthreinsun kreatinins <35 ml/mín.)
English: Fever, flu-like syndrome (including fatigue, rigors, malaise and flushing) Uncommon: Asthenia, peripheral oedema, injection site reactions (including pain, irritation, swelling, induration), chest pain, weight increase, anaphylactic reaction/shock, urticaria
Icelandic: Slen, bjúgur á útlimum, viðbrögð á stungustað (þar með talin verkur, erting, bólga, herslismyndun), brjóstverkur, þyngdaraukning, bráðaofnæmisviðbrögð/lost, ofsakláði
English: Osteonecrosis of the jaw has been reported uncommonly in clinical trials and in the post-marketing setting in patients receiving zoledronic acid.
Icelandic: Greint hefur verið frá sjaldgæfum tilvikum beindreps í kjálka hjá sjúklingum á meðferð með zoledronsýru í klínískum rannsóknum og eftir markaðssetningu lyfsins.
English: The following should be considered when evaluating a patient's risk of developing ONJ: - Potency of the medicinal product that inhibits bone resorption (higher risk for highly potent compounds), route of administration (higher risk for parenteral administration) and cumulative dose of bone resorption therapy.
Icelandic: - Virkni lyfsins sem hamlar beineyðingu (bone resoprtion) (mjög öflugum lyfjum fylgir aukin hætta), íkomuleið (lyfjagjöf utan meltingarvegar fylgir aukin áhætta) og samanlagður skammtur af meðferð við beineyðingu.
English: After dilution: From a microbiological point of view, the diluted solution for infusion should be used immediately.
Icelandic: Með hliðsjón af örverumengun á að nota þynnta innrennslislausn strax.
English: Uveitis
Icelandic: Pamidronat
English: Zoledronic Acid Hospira 4 mg/100 ml solution for infusion Zoledronic acid
Icelandic: Zoledronic Acid Hospira 4 mg/100 ml innrennslislyf, lausn Zoledronsýra
English: How much Zoledronic Acid Hospira is given - The usual single dose given is 4 mg. - If you have a kidney problem, your doctor will give you a lower dose depending on the severity of your kidney problem.
Icelandic: Hve mikið af Zoledronic Acid Hospira er gefið - Venjulegur stakur skammtur er 4 mg.
English: Zoledronic Acid Hospira must not be mixed with other infusion solutions and should be administered as a single intravenous solution in a separate infusion line.
Icelandic: Ekki má blanda Zoledronic Acid Hospira við aðrar innrennslislausnir og það á að gefa eitt sér með innrennsli í bláæð um sér innrennslisslöngu.
English: Tachycardia Respiratory, thoracic and mediastinal disorders Common:
Icelandic: Hraður hjartsláttur Öndunarfæri, brjósthol og miðmæti Algengar:
English: Interstitial lung disease (inflammation of the tissue around the air sacks of the lungs)
Icelandic: -Millivefslungnasjúkdómur (bólga í vef sem umlykur lungnablöðrurnar).
English: Renal impairment has been observed following the administration of zoledronic acid, especially in patients with pre-existing renal dysfunction or additional risk factors (e.g. advanced age, oncology patients with chemotherapy, concomitant nephrotoxic medicinal products, concomitant diuretic therapy, severe dehydration), the majority of whom received a 4 mg dose every 3-4 weeks, but it has been observed in patients after a single administration.
Icelandic: Skert nýrnastarfsemi hefur sést eftir notkun zoledronsýru, einkum hjá sjúklingum sem fyrir voru í hættu vegna ófullnægjandi nýrnastarfsemi eða aðrir áhættuþættir voru til staðar (t.d. hár aldur, krabbameinssjúklingar í krabbameinslyfjameðferð, samhliða notkun lyfja sem hafa eiturverkanir á nýru, samhliða meðferð með þvagræsilyfjum, verulegur vökvaskortur).
English: BAG LABEL
Icelandic: MARKAÐSLEYFISNÚMER
English: One ml of the solution contains 0.04 mg zoledronic acid (as monohydrate).
Icelandic: Einn ml af lausn inniheldur 0,04 mg af zoledronsýru (sem einhýdrat).
English: − The solution containing zoledronic acid must not be further diluted or mixed with other infusion solutions.
Icelandic: - Lausnin sem inniheldur zoledronsýru á ekki að þynna frekar með öðrum innrennslislausnum.
English: What you need to know before you are given Zoledronic Acid Hospira
Icelandic: Áður en byrjað er að gefa þér Zoledronic Acid Hospira
English: Each bag of 100 ml contains 5 mg zoledronic acid (as monohydrate).
Icelandic: Einn 100 ml poki inniheldur 5 mg af zoledronsýru (sem einhýdrat).
English: One vial contains 4 mg of zoledronic acid (as monohydrate).
Icelandic: Einn poki inniheldur 4 mg af zoledronsýru (sem einhýdrat).
English: Each bag with 100 ml of solution contains 5 mg zoledronic acid (as monohydrate).
Icelandic: Hver poki með 100 ml af lausn inniheldur 5 mg af zoledronsýru (sem einhýdrat).
English: How Zoledronic Acid Hospira is used
Icelandic: Zoledronic Acid Hospira inniheldur
English: − Zoledronic Acid Hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously, i.e. through a vein.
Icelandic: - Einungis heilbrigðisstarfsmenn sem eru þjálfaðir í að gefa bisfosfonöt í bláæð mega gefa